Abeona Therapeutics Inc. balance sheet

At the end of fiscal 2025, Abeona Therapeutics Inc. had total assets of $220m, total liabilities of $60.4m and shareholders' equity of $159m. It held $78.4m in cash against $20.0m of debt: net cash of $58.4m.

Balance sheet

US$ millions unless shown otherwise. Fiscal years, plus the last twelve months (LTM) when newer.

Abeona Therapeutics Inc.: balance sheet, annual
Fiscal year	2010Dec 2010	2011Dec 2011	2012Dec 2012	2013Dec 2013	2014Dec 2014	2015Dec 2015	2016Dec 2016	2017Dec 2017	2018Dec 2018	2020Dec 2020	2021Dec 2021	2022Dec 2022	2023Dec 2023	2025Dec 2025	LTMJun 2026
Cash and equivalents	7	2	0	0	12	40	69	138	19	13	33	14	14	78	56
Receivables	1	0	1	0	0	0	0	0	0	—	3	—	—	6	9
Inventory	0	0	0	0	—	—	—	—	—	—	—	—	—	5	6
Total current assets	8	3	2	1	12	41	69	141	89	98	56	53	56	205	165
Goodwill	—	—	—	—	0	32	32	32	32	32	—	—	—	—	—
Total assets	9	4	2	1	17	80	111	179	174	151	80	64	64	220	180
Accounts payable	3	2	2	1	2	1	4	2	6	5	4	2	2	8	3
Deferred revenue (current)	0	0	0	1	1	1	1	3	0	0	0	—	—	—	—
Total current liabilities	14	12	7	9	3	1	8	3	20	42	17	8	13	30	25
Short-term debt	—	—	—	0	0	0	—	—	—	—	—	—	—	12	13
Long-term debt	—	—	—	—	—	—	—	—	—	—	—	—	—	8	2
Total debt	6	6	0	0	0	0	0	0	0	0	0	0	0	20	15
Total liabilities	30	21	19	15	12	12	12	5	40	49	37	37	49	60	51
Shareholders' equity	−21	−18	−17	−15	5	68	99	6	134	103	42	27	15	159	128
Non-controlling interests and other (assets − liabilities − equity)	—	—	—	—	—	—	—	167	—	—	—	—	—	—	—
Net debt (negative = net cash)	−2	3	−0	−0	−11	−40	−69	−138	−19	−13	−33	−14	−14	−58	−41
Shares outstanding	—	—	—	—	—	—	—	—	—	—	24m	—	—	55m	57m

US$ millions unless shown otherwise. Fiscal quarters.

Abeona Therapeutics Inc.: balance sheet, quarterly
Quarter	2023 Q2Jun 2023	2023 Q3Sept 2023	2023 Q4Dec 2023	2025 Q2Jun 2025	2025 Q3Sept 2025	2025 Q4Dec 2025	2026 Q1Mar 2026	2026 Q2Jun 2026
Receivables	4	—	—	—	—	6	6	9
Inventory	—	—	—	3	5	5	6	6
Total current assets	44	57	56	232	216	205	183	165
Total assets	54	66	64	246	231	220	198	180
Accounts payable	3	3	2	7	6	8	4	3
Total current liabilities	9	8	13	35	22	30	31	25
Short-term debt	—	—	—	6	9	12	13	13
Long-term debt	—	—	—	14	11	8	5	2
Total debt	—	—	—	20	20	20	18	15
Total liabilities	44	44	49	83	60	60	54	51
Shareholders' equity	9	22	15	164	171	159	145	128
Shares outstanding	21m	25m	27m	51m	52m	55m	57m	57m

Balances at each fiscal year end (quarter end in the quarterly view). Total debt is short- plus long-term borrowings, including lease debt where the company reports it within debt. Where assets do not equal liabilities plus shareholders' equity, the difference (non-controlling interests, redeemable preferred shares) is shown on its own line.

Compare with peers

Head to head: ABEO vs CRSP ABEO vs JANX ABEO vs STOK

More: Biotechnology stocks compared, Health Care sector, rankings of US companies

Figures from Abeona Therapeutics Inc.'s SEC filings (10-K and 10-Q), retrieved October 29, 2026. How we read and check them: methodology and data sources. Not investment advice. Back to Abeona Therapeutics Inc.